Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
14-17 October, 2024
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
15-17 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
14-17 October, 2024
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
15-17 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-have-built-considerable-expertise-in-glp-1-drug-development-through-our-oral-peptide-programs
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-europe-turn-to-advanced-manufacturing-stockpiling-to-strengthen-drug-supply-chains
18 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kyverna-therapeutics-presents-patient-data-reinforcing-potential-of-kyv-101-for-treatment-of-neuroinflammatory-diseases-in-symposium-at-ectrims-2024-302251529.html
16 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-leadership-update-302248575.html
21 Aug 2024
// BIOSPACE
https://www.biospace.com/kyverna-therapeutics-to-participate-in-upcoming-september-investor-conferences
15 Aug 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/research/wake-celine-dions-diagnosis-and-comeback-stiff-person-syndrome-researchers-and-advocates
12 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kyverna-therapeutics-provides-business-update-and-reports-second-quarter-2024-financial-results-302220289.html
20 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kyvernas-kyv-101-receives-us-fda-ind-clearance-for-treatment-of-patients-with-treatment-refractory-stiff-person-syndrome-in-the-kysa-8-phase-2-trial-302177671.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?